🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › Ohio › Columbus

Qorannoo klinikaalii Baayyee Ulfaataa Columbus, OH keessatti

Qorannoo 13 Baayyee Ulfaataa f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Endocrinology Associates Inc, Columbus
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Namoota walitti qabaa jiraSadarkaa 3
  • Centricity Research - Ohio, Columbus
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Namoota walitti qabaa jiraSadarkaa 1
  • Ohio Clinical Trials, Columbus
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07399678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Namoota walitti qabaa jiraSadarkaa 3
  • Remington-Davis, Inc, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Namoota walitti qabaa jiraSadarkaa 3
  • Nationwide Children's Hospital, Columbus
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-1 Clinical Site, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Remington Davis Inc, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
  • ACCOMPLISH-2 Research Site, Columbus
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Namoota walitti qabaa jiraSadarkaa 3
  • ACCOMPLISH-1 Research Site, Columbus
  • ACCOMPLISH-1 Research Site, Columbus
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The Ohio State University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07702461

Qorannoo Baayyee Ulfaataa magaalota biroo keessatti

Qorannoo biroo Columbus keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.